Register and submit your abstract now to Label-free technologies!
13 April 2012 | By HORIBA Scientific
HORIBA Scientific, is proud to announce the organization of a label-free conference, in cooperation with ELSEVIER...
List view / Grid view
News
Oral lipid-based drug delivery solutions to meet complex bioavailability challenges presented by two global Catalent experts at AAPS workshop
12 April 2012 | By Catalent Pharma Solutions
Dr. Browne & Mr. Meissonnier will present...
Lonza and Agennix sign development and manufacturing deal for production of talactoferrin
Lonza and Agennix AG announced today an agreement for the production of Agennix’s first-in-class oral Dendritic Cell Mediated Immunotherapy (DCMI), talactoferrin, currently in Phase III testing for the treatment of non-small cell lung cancer (NSCLC).
BASF introduces extended solubilization and dermatology excipients portfolios
12 April 2012 | By BASF
After acquiring Cognis in 2011, BASF has significantly expanded its range of solubilization and dermatology excipients...
GSK provides update on corporate responsibility commitments in 2011 report
11 April 2012 | By GlaxoSmithKline
GlaxoSmithKline has published its Corporate Responsibility Report...
Catalent expert invited to share formulation development expertise at Aerosol School
11 April 2012 | By Catalent Pharma Solutions
Dr. Lei Mao, Project Director and Group Leader, R&D of Catalent Pharma Solutions to present...
Abbott’s HUMIRA® (adalimumab) approved in Europe for treatment of ulcerative colitis (UC)
11 April 2012 | By
The European Commission has approved HUMIRA®...
Corning to acquire majority of BD Discovery Labware
Corning Incorporated (NYSE: GLW) announced today that it has reached a definitive agreement with BD (Becton, Dickinson and Company) (NYSE:BDX) to acquire the majority of its Discovery Labware unit for approximately $730 million in cash. The acquisition is expected to be completed later this year, subject to customary closing conditions,…
Around the World in 80 ways – Catalent expert to present on clinical distribution supply chain at 2012 ISPE Japan
10 April 2012 | By Catalent Pharma Solutions
Esther Sadler-Williams will lead two discussions...
Amgen to acquire privately held KAI Pharmaceuticals
10 April 2012 | By Amgen
Amgen and KAI Pharmaceuticals have announced an agreement under which Amgen will acquire KAI...
Abbott receives approval for next-generation XIENCE PRIME™ drug eluting stent in Japan
9 April 2012 | By Abbott
Abbott announced it has received approval from the Japanese MHLW...
Roche disappointed with ISS recommendation
6 April 2012 | By Roche
Roche released the following statement in response to a report issued by Institutional Shareholder Services...
FDA approves Amyvid™
6 April 2012 | By Eli Lilly and Company
Amyvid is the first and only radioactive diagnostic agent approved for PET imaging of beta-amyloid neuritic plaques in the living brain...
FDA decides Teva is sole first-to-file on Provigil®
5 April 2012 | By Teva Pharmaceutical Industries Ltd
Teva Pharmaceuticals USA, is sole first-to-file for both Orange Book patents listed for Provigil® (modafinil)...
Sanofi and Regeneron announce regulatory and clinical update for Zaltrap® (aflibercept)
5 April 2012 | By Sanofi
The FDA has granted Priority Review of the BLA for the investigational agent Zaltrap®...
